ES2965473T3 - Biomarcadores de microARN en suero circulante y métodos para el diagnóstico de la enfermedad de Alzheimer - Google Patents

Biomarcadores de microARN en suero circulante y métodos para el diagnóstico de la enfermedad de Alzheimer Download PDF

Info

Publication number
ES2965473T3
ES2965473T3 ES18742857T ES18742857T ES2965473T3 ES 2965473 T3 ES2965473 T3 ES 2965473T3 ES 18742857 T ES18742857 T ES 18742857T ES 18742857 T ES18742857 T ES 18742857T ES 2965473 T3 ES2965473 T3 ES 2965473T3
Authority
ES
Spain
Prior art keywords
hsa
mir
seq
mirnas
mirna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES18742857T
Other languages
English (en)
Spanish (es)
Inventor
Simon Moller
Ketan Patil
Guido Alves
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
St Johns Univ
St Johns University Taiwan
Original Assignee
St Johns Univ
St Johns University Taiwan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by St Johns Univ, St Johns University Taiwan filed Critical St Johns Univ
Application granted granted Critical
Publication of ES2965473T3 publication Critical patent/ES2965473T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/178Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2814Dementia; Cognitive disorders
    • G01N2800/2821Alzheimer

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
ES18742857T 2017-06-19 2018-06-07 Biomarcadores de microARN en suero circulante y métodos para el diagnóstico de la enfermedad de Alzheimer Active ES2965473T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762521768P 2017-06-19 2017-06-19
PCT/US2018/036377 WO2018236589A1 (en) 2017-06-19 2018-06-07 Circulating serum microrna biomarkers and methods for alzheimer's disease diagnosis

Publications (1)

Publication Number Publication Date
ES2965473T3 true ES2965473T3 (es) 2024-04-15

Family

ID=62952378

Family Applications (1)

Application Number Title Priority Date Filing Date
ES18742857T Active ES2965473T3 (es) 2017-06-19 2018-06-07 Biomarcadores de microARN en suero circulante y métodos para el diagnóstico de la enfermedad de Alzheimer

Country Status (5)

Country Link
US (2) US11634775B2 (enExample)
EP (2) EP3642366B1 (enExample)
JP (1) JP2020524509A (enExample)
ES (1) ES2965473T3 (enExample)
WO (1) WO2018236589A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020000293A (es) * 2017-07-12 2020-07-22 Univ Texas Tech System Microrna-455-3p como un marcador bioperiferico para la enfermedad de alzheimer.
CN111073973A (zh) * 2019-12-10 2020-04-28 石河子大学 一种用于早期诊断2型糖尿病的microRNA序列及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009009457A1 (en) * 2007-07-06 2009-01-15 University Of Louisville Research Foundation, Inc. Alzheimer's disease-specific micro-rna microarray and related methods
US20120108650A1 (en) * 2010-10-29 2012-05-03 Emory University Micro rna markers and methods related thereto
EP2723894B1 (en) * 2011-06-27 2016-05-11 Eisai R&D Management Co., Ltd. Microrna biomarkers indicative of alzheimer's disease
CA2838562A1 (en) * 2011-08-08 2013-02-14 Eugenia Wang Biomarker for alzheimer's disease and/or mild cognitively impairment, and use thereof
WO2013024469A1 (en) 2011-08-16 2013-02-21 Rosetta Genomics Ltd. Methods and compositions for diagnosis of alzheimer's desease
ES2813699T3 (es) 2013-11-18 2021-03-24 Diamir Llc Métodos de uso de miARN de fluidos corporales para la detección y monitoreo de la enfermedad de Parkinson (PD)
WO2015179909A1 (en) 2014-05-26 2015-12-03 The University Of Melbourne Mirna biomarkers of alzheimer's disease
JP6667813B2 (ja) 2015-03-13 2020-03-18 国立大学法人広島大学 アルツハイマー病又は軽度認知症の検出を補助する方法
EP3985130A1 (en) * 2016-02-05 2022-04-20 St. John's University Circulating serum microrna biomarkers and methods for determining parkinson's disease
EP3433381B1 (en) * 2016-03-21 2024-07-24 Diamir, LLC Methods of using mirnas from bodily fluids for detection and differentiation of neurodegenerative diseases

Also Published As

Publication number Publication date
EP3642366A1 (en) 2020-04-29
EP4289970B1 (en) 2025-12-17
EP3642366B1 (en) 2023-11-15
US11634775B2 (en) 2023-04-25
EP3642366C0 (en) 2023-11-15
EP4289970A3 (en) 2024-03-13
US20240209444A1 (en) 2024-06-27
US12398427B2 (en) 2025-08-26
US20200190588A1 (en) 2020-06-18
WO2018236589A1 (en) 2018-12-27
JP2020524509A (ja) 2020-08-20
EP4289970A2 (en) 2023-12-13

Similar Documents

Publication Publication Date Title
Soler-Botija et al. Epigenetic biomarkers in cardiovascular diseases
Dong et al. Serum microRNA profiles serve as novel biomarkers for the diagnosis of Alzheimer’s disease
Nguyen et al. Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low‐risk, localized prostate cancer
US20230323442A1 (en) Circulating serum microrna biomarkers and methods
WO2014082083A1 (en) Biomarker compositions and methods
WO2014193999A2 (en) Biomarker methods and compositions
US12398427B2 (en) Circulating serum microRNA biomarkers and methods for Alzheimer's disease diagnosis
JP2025085828A (ja) パーキンソン病の進行速度を決定するための循環血清マイクロrnaバイオマーカー及び方法
CN110777199B (zh) 干癣性关节炎的诊断及治疗及其相应的试剂盒
Dhandapani et al. MicroRNAs in childhood nephrotic syndrome
JP2017171641A (ja) 前立腺癌治療剤、前立腺癌診断マーカー及びそれを用いた前立腺癌罹患鑑別方法
WO2021063968A1 (en) Method and composition for diagnosing chronic obstructive pulmonary disease
Boroumand et al. Increased circulating miR-10a levels associated with multiple sclerosis
JP2020502263A (ja) Nsclcを有する患者の処置のための薬剤及び応答を予測するための方法
Cameron et al. Circulating MicroRNAs as biomarkers in coronary heart disease and heart failure
Papadopoulos miRNAs in kidney disease